As of 2024-12-14, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (38.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -196.1%.
The range of the Relative Valuation is (16.42) - (59.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 17.3x | 11.0x |
| Forward P/E multiples | 4.8x - 18.5x | 11.6x |
| Fair Price | (16.42) - (59.19) | (38.83) |
| Upside | -140.7% - -246.5% | -196.1% |
| Date | P/E |